Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Temmler
Marburg, Hesse, Germanytemmler.eu ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Temmler was a leading German pharmaceutical manufacturer and CDMO specializing in solid oral dosage forms with expertise in modified-release formulations. It historically developed products for CNS disorders and rare diseases but shifted to contract manufacturing. In recent years its production sites became part of Aenova Group while its neurology product portfolio was acquired by Lupin Limited.
- Therapeutic areas
- PulmonologyGastroenterologyNeurology
- Modalities
- Small moleculeSolid dosage forms (tablets, capsules)Semi-solid and liquid dosage formsModified release formulations
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Temmler.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Temmler.